@FierceBiotech: New special report on FierceVaccines.com: 10 promising therapeutic vaccines in 2012. Feature | Follow @FierceBiotech
@JohnCFierce: Genzyme, $ISIS likely to get some tough safety questions on Kynamro at this week's FDA panel. More | Follow @JohnCFierce
@RyanMFierce: Piramal is poised to be a big consolidator in pharma services/manufacturing, but apparently only at the right price. More | Follow @RyanMFierce
> Novo Nordisk ($NVO) has filed for regulatory approval of its hemophilia drug Turoctocog Alfa in the U.S. and Europe. Report
> Fate Therapeutics named Christian Weyer as its new president and chief executive officer. Release
> China's Shenzhen Hepalink Pharmaceutical is making a $10 million investment in Canada's ProMetic Life Sciences while striking two R&D pacts worth up to $21 million. Story
Pharma News
@FiercePharma: Other compounded drugs may be tied into meningitis outbreak, FDA says. Another NECC steroid + NECC heart drug. More | Follow @FiercePharma
> J&J credits Remicade, Zytiga for 7% hike in Q3 drug sales. Story
> Roche sales hike sums up pharma hopes for cancer, emerging markets. Article
> India kicks branded generics to the curb. Report
@FierceMedDev: JNJ pulled in $7.1 billion from medical devices and diagnostics in Q3, a 12.5% jump. More | Follow @FierceMedDev
@MarkHFierce: Patients in India thrived with used ICD implants. Can this be done on a broader scale? More | Follow @MarkHFierce
@DamianFierce: Medtronic is buying a $66.2M stake in China's LifeTech Scientific, makers of cardiovascular devices. More | Follow @DamianFierce
> Amid Dx sales growth, Roche Diagnostics considers another buy. News
> Lanx draws $8.7M for spinal fusion device development. Item
Biotech Research News
> NIH funds Advanced Cancer Therapeutics' preclinical brain cancer drug work. Report
> Scientists flee $3B Texas cancer research fund. Item
> Alnylam, Tel Aviv U develop RNAi drugs to fight rare blood cancer. Article
> Alzheimer's drug builds new brain cell connections in rats. News
> Scientists build neural-like stem cells from mouse muscle tissue. Story
Pharma Manufacturing News
> GSK cancels plans to close Stiefel plant in Ireland. Story
> Cinven continues generics deal spree with Amdipharm buy. Article
> Teva Pharma opens $110M plant in Hungary. News
> Analysis: Compounding groups fought FDA oversight before NECC disaster. Report
And Finally... Postdoctoral Research Fellow Devin Koestler and colleagues are investigating the potential use of white blood cell variation as a diagnostic and research tool for cancer. Release